Synthesis and characterization of

Anserine Carnosine Histidine dipeptides Isotope dilution mass spectrometry Quantitative analysis Synthesis

Journal

Talanta
ISSN: 1873-3573
Titre abrégé: Talanta
Pays: Netherlands
ID NLM: 2984816R

Informations de publication

Date de publication:
01 Dec 2021
Historique:
received: 30 04 2021
revised: 23 07 2021
accepted: 24 07 2021
entrez: 14 9 2021
pubmed: 15 9 2021
medline: 16 9 2021
Statut: ppublish

Résumé

Due to the physiological properties of l-carnosine (l-1), supplementation of this dipeptide has both a nutritional ergogenic application and a therapeutic potential for the treatment of numerous diseases in which ischemic or oxidative stress are involved. Quantitation of carnosine and its analogs in biological matrices results to be crucial for these applications and HPLC-MS procedures with isotope-labeled internal standards are the state-of-the-art approach for this analytical need. The use of these standards allows to account for variations during the sample preparation process, between-sample matrix effects, and variations in instrument performance over analysis time. Although literature reports a number of studies involving carnosine, isotope-labeled derivatives of the dipeptide are not commercially available. In this work we present a fast, flexible, and convenient strategy for the synthesis of the

Identifiants

pubmed: 34517610
pii: S0039-9140(21)00663-9
doi: 10.1016/j.talanta.2021.122742
pii:
doi:

Substances chimiques

Dipeptides 0
Carnosine 8HO6PVN24W
Anserine HDQ4N37UGV

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

122742

Informations de copyright

Copyright © 2021 Elsevier B.V. All rights reserved.

Auteurs

Marco Maspero (M)

Department of Pharmaceutical Sciences, Medicinal Chemistry Section "Pietro Pratesi", University of Milan, Via L. Mangiagalli 25, 20133, Milan, Italy.

Ettore Gilardoni (E)

Department of Pharmaceutical Sciences, Medicinal Chemistry Section "Pietro Pratesi", University of Milan, Via L. Mangiagalli 25, 20133, Milan, Italy.

Chiara Bonfanti (C)

Department of BioSciences, University of Milan, Via Celoria 26, 20133, Milan, Italy.

Graziella Messina (G)

Department of BioSciences, University of Milan, Via Celoria 26, 20133, Milan, Italy.

Luca Regazzoni (L)

Department of Pharmaceutical Sciences, Medicinal Chemistry Section "Pietro Pratesi", University of Milan, Via L. Mangiagalli 25, 20133, Milan, Italy.

Marco De Amici (M)

Department of Pharmaceutical Sciences, Medicinal Chemistry Section "Pietro Pratesi", University of Milan, Via L. Mangiagalli 25, 20133, Milan, Italy.

Marina Carini (M)

Department of Pharmaceutical Sciences, Medicinal Chemistry Section "Pietro Pratesi", University of Milan, Via L. Mangiagalli 25, 20133, Milan, Italy.

Giancarlo Aldini (G)

Department of Pharmaceutical Sciences, Medicinal Chemistry Section "Pietro Pratesi", University of Milan, Via L. Mangiagalli 25, 20133, Milan, Italy.

Clelia Dallanoce (C)

Department of Pharmaceutical Sciences, Medicinal Chemistry Section "Pietro Pratesi", University of Milan, Via L. Mangiagalli 25, 20133, Milan, Italy. Electronic address: clelia.dallanoce@unimi.it.

Articles similaires

Humans Chromatography, High Pressure Liquid Acetaminophen COVID-19 SARS-CoV-2
Humans Breast Neoplasms Female Mass Spectrometry Adipose Tissue
Humans Proteomics Paraffin Embedding Tissue Fixation Organelles
Animals Alzheimer Disease Mice Proteomics Disease Models, Animal

Classifications MeSH